Adicet Bio Stock Probability of Future Stock Price Finishing Over 2.33

ACET Stock  USD 2.33  0.09  4.02%   
Adicet Bio's implied volatility is one of the determining factors in the pricing options written on Adicet Bio. Implied volatility approximates the future value of Adicet Bio based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Adicet Bio over a specific time period. For example, 2024-04-19 PUT at $2.5 is a PUT option contract on Adicet Bio's common stock with a strick price of 2.5 expiring on 2024-04-19. The contract was last traded on 2024-03-20 at 12:57:51 for $0.5 and, as of today, has 22 days remaining before the expiration. The option is currently trading at a bid price of $0.3, and an ask price of $0.65. The implied volatility as of the 28th of March is 165.46. View All Adicet options

Closest to current price Adicet long PUT Option Payoff at Expiration

Adicet Bio's future price is the expected price of Adicet Bio instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Adicet Bio performance during a given time horizon utilizing its historical volatility. Check out Adicet Bio Backtesting, Adicet Bio Valuation, Adicet Bio Correlation, Adicet Bio Hype Analysis, Adicet Bio Volatility, Adicet Bio History as well as Adicet Bio Performance.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.
  
At this time, Adicet Bio's Price To Sales Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.44 in 2024, despite the fact that Price To Operating Cash Flows Ratio is likely to grow to (8.96). Please specify Adicet Bio's target price for which you would like Adicet Bio odds to be computed.

Adicet Bio Target Price Odds to finish over 2.33

The tendency of Adicet Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 2.33 90 days 2.33 
about 64.62
Based on a normal probability distribution, the odds of Adicet Bio to move above the current price in 90 days from now is about 64.62 (This Adicet Bio probability density function shows the probability of Adicet Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.69 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Adicet Bio will likely underperform. Additionally Adicet Bio has an alpha of 0.7618, implying that it can generate a 0.76 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Adicet Bio Price Density   
       Price  

Predictive Modules for Adicet Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Adicet Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Adicet Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.122.3510.56
Details
Intrinsic
Valuation
LowRealHigh
0.346.7714.98
Details
8 Analysts
Consensus
LowTargetHigh
18.5020.3322.57
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.51-0.39-0.27
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Adicet Bio. Your research has to be compared to or analyzed against Adicet Bio's peers to derive any actionable benefits. When done correctly, Adicet Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Adicet Bio.

Adicet Bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Adicet Bio is not an exception. The market had few large corrections towards the Adicet Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Adicet Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Adicet Bio within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
0.76
β
Beta against NYSE Composite1.69
σ
Overall volatility
0.48
Ir
Information ratio 0.11

Adicet Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Adicet Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Adicet Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Adicet Bio is way too risky over 90 days horizon
Adicet Bio appears to be risky and price may revert if volatility continues
Net Loss for the year was (142.66 M) with profit before overhead, payroll, taxes, and interest of 24.99 M.
Adicet Bio currently holds about 260.64 M in cash with (93.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Adicet Bio has a poor financial position based on the latest SEC disclosures
Roughly 68.0% of the company shares are held by institutions such as insurance companies
Latest headline from simplywall.st: Disposition of 56612 shares by Blake Aftab of Adicet Bio at 7.38 subject to Rule 16b-3

Adicet Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Adicet Stock often depends not only on the future outlook of the current and potential Adicet Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adicet Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding43.3 M

Adicet Bio Technical Analysis

Adicet Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Adicet Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Adicet Bio. In general, you should focus on analyzing Adicet Stock price patterns and their correlations with different microeconomic environments and drivers.

Adicet Bio Predictive Forecast Models

Adicet Bio's time-series forecasting models is one of many Adicet Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Adicet Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Adicet Bio

Checking the ongoing alerts about Adicet Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Adicet Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Adicet Bio is way too risky over 90 days horizon
Adicet Bio appears to be risky and price may revert if volatility continues
Net Loss for the year was (142.66 M) with profit before overhead, payroll, taxes, and interest of 24.99 M.
Adicet Bio currently holds about 260.64 M in cash with (93.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Adicet Bio has a poor financial position based on the latest SEC disclosures
Roughly 68.0% of the company shares are held by institutions such as insurance companies
Latest headline from simplywall.st: Disposition of 56612 shares by Blake Aftab of Adicet Bio at 7.38 subject to Rule 16b-3
When determining whether Adicet Bio is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Adicet Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Adicet Bio Stock. Highlighted below are key reports to facilitate an investment decision about Adicet Bio Stock:
Check out Adicet Bio Backtesting, Adicet Bio Valuation, Adicet Bio Correlation, Adicet Bio Hype Analysis, Adicet Bio Volatility, Adicet Bio History as well as Adicet Bio Performance.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.
Note that the Adicet Bio information on this page should be used as a complementary analysis to other Adicet Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Adicet Stock analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Adicet Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adicet Bio. If investors know Adicet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adicet Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.31)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.31)
Return On Equity
(0.62)
The market value of Adicet Bio is measured differently than its book value, which is the value of Adicet that is recorded on the company's balance sheet. Investors also form their own opinion of Adicet Bio's value that differs from its market value or its book value, called intrinsic value, which is Adicet Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adicet Bio's market value can be influenced by many factors that don't directly affect Adicet Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adicet Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adicet Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adicet Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.